Javascript must be enabled to continue!
Lysine Acetyltransferase 8-Mediated Histone Acetylation Regulated by GBA1 is Associated with Lysosomal Function Related to α-Synuclein Pathology
View through CrossRef
Abstract
Lysosomal defects are closely linked to Parkinson’s disease (PD). Mutations in the GBA1 gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), are major genetic risk factors for PD. GBA1 deficiency causes lysosomal dysfunction, leading to α-synuclein (α-syn) accumulation and PD progression. However, the underlying mechanisms remain unclear. In this study, we identified a novel GBA1-KAT8 regulatory pathway that controls lysosomal activity. GBA1 overexpression enhances lysosomal enzyme expression, regulates histone H4 acetylation at K16 via KAT8, and promotes lysosome-associated gene expression, highlighting an epigenetic mechanism in lysosomal biogenesis. Furthermore, GBA1 upregulated KAT8 expression, increased lysosomal enzyme levels, and decreased PFF-induced α-syn accumulation both in vitro and in vivo. The involvement of KAT8 as a critical acetyltransferase that modulates nuclear–lysosomal signaling pathways provides a mechanistic explanation for GBA1 deficiency-induced lysosomal dysfunction in association with PD pathology.
Springer Science and Business Media LLC
Title: Lysine Acetyltransferase 8-Mediated Histone Acetylation Regulated by GBA1 is Associated with Lysosomal Function Related to α-Synuclein Pathology
Description:
Abstract
Lysosomal defects are closely linked to Parkinson’s disease (PD).
Mutations in the GBA1 gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), are major genetic risk factors for PD.
GBA1 deficiency causes lysosomal dysfunction, leading to α-synuclein (α-syn) accumulation and PD progression.
However, the underlying mechanisms remain unclear.
In this study, we identified a novel GBA1-KAT8 regulatory pathway that controls lysosomal activity.
GBA1 overexpression enhances lysosomal enzyme expression, regulates histone H4 acetylation at K16 via KAT8, and promotes lysosome-associated gene expression, highlighting an epigenetic mechanism in lysosomal biogenesis.
Furthermore, GBA1 upregulated KAT8 expression, increased lysosomal enzyme levels, and decreased PFF-induced α-syn accumulation both in vitro and in vivo.
The involvement of KAT8 as a critical acetyltransferase that modulates nuclear–lysosomal signaling pathways provides a mechanistic explanation for GBA1 deficiency-induced lysosomal dysfunction in association with PD pathology.
Related Results
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Microencapsulated Escape Lysine with Tannin as an Adjuvant in Sheep Diets
Microencapsulated Escape Lysine with Tannin as an Adjuvant in Sheep Diets
The use of escape protein, which is absorbed in the small intestine, can improve the production of ruminant animals because it meets their protein requirements better. This study h...
Dynamic acetylation of a conserved lysine impacts glycerol kinase activity and abundance in the haloarchaeon
Haloferax volcanii
Dynamic acetylation of a conserved lysine impacts glycerol kinase activity and abundance in the haloarchaeon
Haloferax volcanii
ABSTRACT
Haloferax volcanii
is a halophilic archaeon that preferentially utilizes glycerol as a carbon source, placing glycerol...
Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes)
Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes)
AbstractHomozygous mutations in the lysosomal glucocerebrosidase gene, GBA1, cause Gaucher’s disease (GD), while heterozygous mutations in GBA1 are a strong risk factor for Parkins...
Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
Alpha-synuclein is a 140 aa neuronal protein pathologically and
genetically linked to Parkinson’s disease (PD). In PD, the major protein
modification of alpha-synuclein is phosphor...
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
ABSTRACT
Alpha‐synuclein is a 140 aa neuronal protein pathologically and genetically linked to Parkinson's disease (PD). In PD, the major pro...
Caractérisation structurale et fonctionnelle de mutations oncogéniques de l'histone méthyltransférase SETD2 et de l'histone acétyltransférase MOZ
Caractérisation structurale et fonctionnelle de mutations oncogéniques de l'histone méthyltransférase SETD2 et de l'histone acétyltransférase MOZ
Chez l'Homme, SET Domain containing 2 (SETD2) est la principale histone méthyltransférase responsable de la triméthylation de la lysine 36 de l'histone H3 (H3K36) pour donner la ma...
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the mo...

